| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/14/2001 | US6274318 Detecting modulators of enzyme activity; incubate enzymatic sample and inhibitor, detect reduce activity from enzyme |
| 08/14/2001 | US6274316 Detecting antibiotic resistant bacteria; lyse cells, incubate with probes, detect split segments of probes |
| 08/14/2001 | US6274313 Oligonucleotides with cationic phosphoramidate internucleoside linkages and methods of use |
| 08/14/2001 | US6274311 Isolated nucleic acid encoding a eukaryotic malate permease from schizosaccharomyces pombe which mediates the uptake of l-malate, succinate, and malonate; fermenation of wine |
| 08/14/2001 | US6274149 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| 08/14/2001 | US6274148 Hepatitis C virus asialoglycoproteins |
| 08/14/2001 | US6274147 Preparing cdna of infectious pancreatic necrosis virus genome, initiating replication of ds rna in host cell using rna derived from cdna, incubating host cell in culture medium, and isolating live, infectious pancreatic necrosis virus |
| 08/14/2001 | US6274145 To generate cytolytic t cells against abnormal cells; as markers for pathological or abnormal condition in diagnosis |
| 08/14/2001 | US6274143 Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10 |
| 08/14/2001 | US6274139 For therapy of bacterial infections |
| 08/14/2001 | US6274136 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| 08/14/2001 | US6274134 Human cell adhesion protein AAMP-1 and uses thereof |
| 08/14/2001 | US6274117 Cytokines that bind the cell surface receptor Hek |
| 08/14/2001 | US6272939 System and method for filling a substrate with a liquid sample |
| 08/14/2001 | CA2258567C Maize promoter sequence for leaf- and stalk-preferred gene expression |
| 08/14/2001 | CA2243570C Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 08/14/2001 | CA2185155C Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 08/14/2001 | CA2108247C Oligonucleotides derived from the sod family |
| 08/14/2001 | CA2032035C Fungal expression system |
| 08/14/2001 | CA2012312C Genetic units for inhibiting the function of rna |
| 08/14/2001 | CA1341284C Site-directed mutagenesis modified glycoprotein hormones and methods of use |
| 08/14/2001 | CA1341283C Biological pesticides and methods for their delivery and use |
| 08/12/2001 | CA2296052A1 Rice cysteine proteinase gene promoter |
| 08/10/2001 | CA2331876A1 Water-soluble ligand-binding proteins and analogs of ligand-gated channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/09/2001 | WO2001057519A2 Method for identifying and/or characterizing a (poly)peptide |
| 08/09/2001 | WO2001057278A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human hela cells or other human cervical epithelial cells |
| 08/09/2001 | WO2001057277A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human fetal liver |
| 08/09/2001 | WO2001057276A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow |
| 08/09/2001 | WO2001057275A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain |
| 08/09/2001 | WO2001057274A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart |
| 08/09/2001 | WO2001057273A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver |
| 08/09/2001 | WO2001057272A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human placenta |
| 08/09/2001 | WO2001057271A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells |
| 08/09/2001 | WO2001057270A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and hbl 100 cells |
| 08/09/2001 | WO2001057269A2 Nucleic acid detection methods using universal priming |
| 08/09/2001 | WO2001057267A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | WO2001057265A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057264A2 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057259A1 Signaling aptamers that transduce molecular recognition to a differential signal |
| 08/09/2001 | WO2001057257A2 Isolation and identification of mrnas correlating to secreted proteins |
| 08/09/2001 | WO2001057252A2 Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes |
| 08/09/2001 | WO2001057251A2 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| 08/09/2001 | WO2001057249A1 Synthesis of spatially addressed molecular arrays |
| 08/09/2001 | WO2001057248A2 Polynucleotide arrays and their use in sequencing |
| 08/09/2001 | WO2001057244A1 AN ASSAY FOR DETECTING VARIANT HAPATITIS B VIRUSES (HBVs) WHICH EXHIBIT ALTERED SENSITIVITY TO AGENTS |
| 08/09/2001 | WO2001057242A2 Methods of protein destabilization and uses thereof |
| 08/09/2001 | WO2001057234A2 Biopolymer thickener |
| 08/09/2001 | WO2001057233A2 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057228A1 Methods for treatment of restenosis using adenoviral vectors and transgene products |
| 08/09/2001 | WO2001057226A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | WO2001057225A1 Protein having pge2 synthase activity and use thereof |
| 08/09/2001 | WO2001057224A2 Allene oxide cyclase gene and use thereof for producing jasmonic acid |
| 08/09/2001 | WO2001057223A1 Enzyme in non-mevalonate pathway and gene encoding the same |
| 08/09/2001 | WO2001057222A1 A protease, a gene therefor and the use thereof |
| 08/09/2001 | WO2001057221A2 Dsp-12 and dsp-13 dual-specificity phosphatases |
| 08/09/2001 | WO2001057220A2 Human enzymes and polynucleotides encoding the same |
| 08/09/2001 | WO2001057219A2 Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods |
| 08/09/2001 | WO2001057218A1 A process for producing purified biologically active, free form of recombinant human interferon gamma |
| 08/09/2001 | WO2001057217A1 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same |
| 08/09/2001 | WO2001057216A2 Method for the production of a protein |
| 08/09/2001 | WO2001057215A2 Human g-protein coupled receptor polypeptides and polynucleotides having homology with odorant receptors |
| 08/09/2001 | WO2001057214A2 Human transporter proteins and polynucleotides encoding the same |
| 08/09/2001 | WO2001057213A2 Human bcl-x-like proteins and polynucleotides encoding the same |
| 08/09/2001 | WO2001057212A1 Rapid, parallel identification of cell lines |
| 08/09/2001 | WO2001057211A1 Soluble t cell receptor protein and method of constructing the same |
| 08/09/2001 | WO2001057210A2 Use of dendroaspin as a vehicle for non-dendroaspin domains |
| 08/09/2001 | WO2001057209A2 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof |
| 08/09/2001 | WO2001057208A2 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 08/09/2001 | WO2001057207A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/09/2001 | WO2001057206A2 Method and reagent for the inhibition of checkpoint kinase-1 (chk 1) enzyme |
| 08/09/2001 | WO2001057205A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr |
| 08/09/2001 | WO2001057204A1 Virus envelope vector for gene transfer |
| 08/09/2001 | WO2001057201A2 Root transcriptional factors and methods of use |
| 08/09/2001 | WO2001057200A2 Root transcriptional factors and methods of use |
| 08/09/2001 | WO2001057198A2 Methods of generating protein expression arrays and the use thereof in rapid screening |
| 08/09/2001 | WO2001057196A1 Plant adpglucose pyrophosphatase, method for the production thereof, its use in the production of assay devices and for obtaining transgenic plants |
| 08/09/2001 | WO2001057194A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/09/2001 | WO2001057193A2 Protein c derivatives |
| 08/09/2001 | WO2001057182A2 Nucleic acids, proteins, and antibodies |
| 08/09/2001 | WO2001057175A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057090A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 08/09/2001 | WO2001057088A1 RUMINANT MHC CLASS I-LIKE Fc RECEPTORS |
| 08/09/2001 | WO2001057087A2 High affinity immunoglobulin epsilon receptor beta-subunit-like protein and nucleic acids encoding same |
| 08/09/2001 | WO2001057086A2 Novel human g protein coupled receptor proteins and polynucleotides encoding the same |
| 08/09/2001 | WO2001057085A2 G-protein coupled receptors |
| 08/09/2001 | WO2001057081A2 Narc-1, subtilase-like homologs |
| 08/09/2001 | WO2001057080A2 Neuropeptide-like polypeptide zpep17 |
| 08/09/2001 | WO2001057079A2 C1 inhibitor produced in the milk of transgenic mammals |
| 08/09/2001 | WO2001057077A1 Proteins that are specifically expressed or highly overexpressed in tumors and nucleic acids encoding them |
| 08/09/2001 | WO2001057075A2 Virulence genes, proteins, and their use |
| 08/09/2001 | WO2001057073A2 Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
| 08/09/2001 | WO2001057069A2 Targeting peptides |
| 08/09/2001 | WO2001057068A1 Mucin-1 derived antigens and their use in immunotherapy |
| 08/09/2001 | WO2001057067A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | WO2001057065A2 Combinatorial protein domains |
| 08/09/2001 | WO2001057063A1 Eto1 and related proteins, and methods of regulating ethylene biosynthesis |
| 08/09/2001 | WO2001057061A1 Novel use of ribozymes to block gene expression |
| 08/09/2001 | WO2001057060A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | WO2001057059A1 Antisense modulation of survivin expression |